Nisarga Biotech Private Ltd
FDA import alert and refusal historySatara, IndiaFEI 2000001491
As of October 26, 2026, Nisarga Biotech Private Ltd (Satara, India) is on the red list of FDA Import Alert 99-39 (Imported foods that appear to be misbranded) for ocimum sanctum extract, published by FDA on February 14, 2017, and has 6 FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-39 · red list
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · LIST INGRE
- Last warning letter
- None found
- Last inspection
- Classified VAI (Voluntary Action Indicated)
Every FDA record for Nisarga Biotech Private Ltd
9 records, newest first. Each line links to the FDA page it came from.
2023
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.LIST INGRELACKS FIRMLABELINGNUTRIT LBLHEALTH CEntry 799-7953409-6Source
- Import refusalRefused, Holy basil (herbal & botanicals, not teas ii)FALSEEntry 799-6895157-4Source
2021
2019
- InspectionInspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological HazardsSource
2018
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNSAFE ADDFALSEPOISONOUSEntry KM6-1518416-5Source
2017
- Import alert listingListed on Import Alert 99-39red listOcimum Sanctum ExtractSource
2016
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNSAFE ADDPOISONOUSEntry 9WH-1013994-7Source
- Import refusalRefused, Ashwagandha (herbal & botanicals, not teas)LABELINGNUTRIT LBLEntry EG6-3830116-8Source
2015
- InspectionInspection classified VAI (Voluntary Action Indicated)Foodborne Biological HazardsSource
Refusal charges, in plain English
- FALSE3 refused lines
False or misleading labeling
The labeling appeared to be false or misleading in some particular.
- LABELING2 refused lines
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- NUTRIT LBL2 refused lines
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
- POISONOUS2 refused lines
Poisonous or deleterious substance
The product appeared to bear or contain a poisonous or deleterious substance which may render it injurious to health.
- UNSAFE ADD2 refused lines
Food additive unsafe under section 409
The product appeared to contain a food additive that is unsafe within the meaning of section 409 of the FD&C Act, the section that governs which food additives may be used and under what conditions.
- HEALTH C1 refused line
Unauthorized nutrient content or health claim
The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.
- LACKS FIRM1 refused line
Manufacturer name and address missing
The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.
- LIST INGRE1 refused line
Ingredients not listed
The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).
Questions about Nisarga Biotech Private Ltd
- Is Nisarga Biotech Private Ltd on an FDA import alert?
- Yes. As of October 26, 2026, Nisarga Biotech Private Ltd is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for ocimum sanctum extract; FDA published the listing on February 14, 2017.
- Has FDA refused shipments from Nisarga Biotech Private Ltd?
- Yes. FDA refused 6 shipment lines from Nisarga Biotech Private Ltd between November 21, 2016 and December 5, 2023. The most recent, on December 5, 2023, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as LIST INGRE (ingredients not listed).
- Why did FDA refuse Nisarga Biotech Private Ltd's shipments?
- The most frequent charges are FALSE (false or misleading labeling, 3 lines) and LABELING (fair packaging and labeling act, 2 lines).
- When was Nisarga Biotech Private Ltd last inspected by FDA?
- FDA's most recent inspection of Nisarga Biotech Private Ltd with a final classification is dated June 4, 2019 and was classified VAI (Voluntary Action Indicated).
- What is Nisarga Biotech Private Ltd's FEI number?
- Nisarga Biotech Private Ltd's FDA Establishment Identifier (FEI) is 2000001491.
- Can shipments from Nisarga Biotech Private Ltd still enter the U.S.?
- Shipments of ocimum sanctum extract from Nisarga Biotech Private Ltd can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Nisarga Biotech Private Ltd?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.